1. YKL-40-Induced Inhibition of miR-590-3p Promotes Interleukin-18 Expression and Angiogenesis of Endothelial Progenitor Cells
   Te-Mao Li et al, 2017, IJMS CrossRef
2. Regulation of microRNA using promising dietary phytochemicals: Possible preventive and treatment option of malignant mesothelioma
   Md. Abu Sayeed et al, 2017, Biomedicine & Pharmacotherapy CrossRef
3. ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion.
   Valeriana Cesarini et al, 2018, Nucleic Acids Res CrossRef
4. MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF-1R-mediated AKT and ERK pathways
   Fangzheng Zhou et al, 2017 CrossRef
5. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer
   Meizhong Xu et al, 2017 CrossRef
6. MiR-411 Functions as a Tumor Suppressor in Renal Cell Cancer
   Xintao Zhang et al, 2017, The International Journal of Biological Markers CrossRef
7. Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379
   K. P. O’Brien et al, 2018, Oncogene CrossRef
8. circ-SHKBP1 Regulates the Angiogenesis of U87 Glioma-Exposed Endothelial Cells through miR-544a/FOXP1 and miR-379/FOXP2 Pathways
   Qianru He et al, 2018, Molecular Therapy - Nucleic Acids CrossRef
9. MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression
   Zhange Yu et al, 2018, Environ Sci Pollut Res CrossRef
10. Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP
    Caiyan Zhang et al, 2018, Oncogene CrossRef
11. Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma
    Bernhard Biersack, 2018, Non-coding RNA Research CrossRef
12. MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review
    Giuseppe Lo Russo et al, 2018, Front. Oncol. CrossRef
13. Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy
    XUDONG XIE et al, 2019, Cytotherapy CrossRef
14. Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells
    Abu Musa Md Talimur Reza et al, 2016, Sci Rep CrossRef
15. Cluster miRNAs and cancer: Diagnostic, prognostic and therapeutic opportunities.
    Shama Prasada Kabekkodu et al, 2020, Wiley Interdiscip Rev RNA CrossRef
16. null
    Derek W. Edwardson et al, 2019 CrossRef
17. MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1
    Zheng Li et al, 2017, J. Cell. Mol. Med. CrossRef
18. miR-379 Inhibits Cell Proliferation, Invasion, and Migration of Vascular Smooth Muscle Cells by Targeting Insulin-Like Factor-1
    Kai Li et al, 2017, Yonsei Med J CrossRef
19. Suppression of EIF4G2 by miR-379 potentiates the cisplatin chemosensitivity in nonsmall cell lung cancer cells
    Guang-jun Hao et al, 2017, FEBS Lett CrossRef
20. DLK1-DIO3imprinted locus deregulation in development, respiratory disease, and cancer
    Jhon R. Enterina et al, 2017, Expert Review of Respiratory Medicine CrossRef
21. MicroRNA‐379 mediates pigmentation, migration and proliferation of melanocytes by targeting the insulin‐like growth factor 1 receptor
    Bo Liu et al, 2020, Exp Dermatol CrossRef
22. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis
    Luigina Micolucci et al, 2016, Oncotarget CrossRef
23. Identification of crucial miRNAs and lncRNAs for ossification of ligamentum flavum
    Daliang Kong et al, 2019, Mol Med Report CrossRef
24. MicroRNA-379 inhibits cell proliferation and invasion in glioma via targeting metadherin and regulating PTEN/AKT pathway
    Li Li et al, 2017, Mol Med Report CrossRef
25. Identification of Ovine Serum miRNAs Following Bacterial Lipopolysaccharide Challenge
    Ankita Sharma et al, 2020, IJMS CrossRef
26. DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs
    Go Oshima et al, 2019, Cancer Res CrossRef
27. MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy
    Hong Zhou et al, 2021, Front. Cell Dev. Biol. CrossRef
28. An update on the role of miR-379 in human disorders
    Soudeh Ghafouri-Fard et al, 2021, Biomedicine & Pharmacotherapy CrossRef
29. MicroRNA-379 Suppresses Cervical Cancer Cell Proliferation and Invasion by Directly Targeting V-crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like (CRKL)
    Xi Shi et al, 2018, oncol res CrossRef
30. Dysregulation of miR-411 in cancer: Causative factor for pathogenesis, diagnosis and prognosis
    Mengsha Zou et al, 2022, Biomedicine & Pharmacotherapy CrossRef
31. Deciphering key genes and miRNAs associated with Hepatocellular carcinoma via network-based approach
    Sachin Bhatt et al, 2020, IEEE/ACM Trans. Comput. Biol. and Bioinf. CrossRef
32. Splicing deregulation, microRNA and Notch aberrations: fighting the three-headed dog to overcome drug resistance in malignant mesothelioma
    Dario P. Anobile et al, 2022, Expert Review of Clinical Pharmacology CrossRef
33. Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma
    Botle Precious Setlai et al, 2022, IJMS CrossRef
34. MicroRNAs: Key modulators of inflammation-associated diseases
    Bilash Chatterjee et al, 2023, Seminars in Cell & Developmental Biology CrossRef
35. Circular RNA circ_0000741/miR-379-5p/TRIM14 signaling axis promotes HDAC inhibitor (SAHA) tolerance in glioblastoma
    Liang Meng et al, 2023, Metab Brain Dis CrossRef
36. Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma
    Mai A. Abd-Elmawla et al, 2023, Pathology - Research and Practice CrossRef